Clinical Trial Update: Effects of Ranolazine on Coronary Flow Reserve in Symptomatic Diabetic Patients and CAD [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial assessing the effect of ranolazine on coronary flow reserve in symptomatic diabetic patients with coronary artery disease has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angina Pectoris
• Coronary Artery Disease
• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• Ranolazine (ranolazine)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Diabetes, Type I, Diabetes, Type II | Phase 3 | Status: COMPLETED | Results posted: 2017-07-24